EUIPO trademark

Zytomics

RegisteredEUIPOWord markClass 1Class 5Class 9Class 10+3

"Zytomics" is a word mark owned by ZytoVision GmbH, filed at the EUIPO on May 5, 2023. It is registered and covers classes 1, 5, 9, 10, 35, 42 and 44.

View ZytoVision GmbH portfolioGet this data via the API
Official EUIPO record
Zytomics
Word mark as filed with the EUIPO
Status
Registered
Since September 13, 2023
Filed
May 5, 2023
Registered
September 12, 2023
Expires
May 5, 2033
Application no.
018870803
Registration no.
018870803
Office
EUIPO
European Union Intellectual Property Office
Mark type
Word mark
7 classes
Ownership

Who owns Zytomics

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

ZytoVision GmbH

23 trademarks in the portfolioView company

Representative

Meissner Bolte Patentanwälte Rechtsanwälte Partnerschaft MBB

Meissner Bolte Patentanwälte Rechtsanwälte Partnerschaft MBB

Goods and services

What the mark covers

The products and services Zytomics is filed for, grouped by Nice class.

  • Chemicals for use in industry and science; Chemicals, Biochemicals, for use in the following fields: pathology, Genetics, Human genetics, molecular pathologies, Molecular biology, Microbiology, Biotechnology, Laboratory medicine; Chemicals and biochemicals for histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, PCR (polymerase chain reaction), NGS (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry services and isolation of biomolecules including DNA, RNA and proteins; Nucleic acids (including DNA, RNA, oligonucleotides, polynucleotides, marked nucleic acids and modified nucleic acids), proteins (including peptides, recombinant proteins and marked proteins), antibodies, DNA probes being biochemical substances, RNA probes being biochemical substances, oligonucleotide probes being biochemical substances, cells, tissue, tissue sections, and nucleic acids, proteins and cells immobilised on carriers

  • Pharmaceuticals and medical preparations; Medical preparations for diagnostics; Medical preparations for in-vitro diagnostics; Pharmaceuticals, Pharmaceutical preparations, medical products, Medical preparations, Chemical products, chemical preparations, Biochemical products, Biochemical preparations, For medical purposes, for use in the following fields: pathology, Genetics, Human genetics, molecular pathologies, Molecular biology, Microbiology, biotechnology, laboratory medicine; Pharmaceutical, medicated, chemical and biochemicals and preparations for medical purposes for histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, PCR (polymerase chain reaction), NGS (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry services and isolation of biomolecules including DNA, RNA and proteins; Nucleic acids (including DNA, RNA, oligonucleotides, polynucleotides, marked nucleic acids and modified nucleic acids), proteins (including peptides, recombinant proteins and marked proteins), antibodies, DNA probes being biochemical substances, RNA probes being biochemical substances, oligonucleotide probes being biochemical substances, cells, tissue, tissue sections, and nucleic acids, proteins and cells immobilised on carriers

  • Scientific research and laboratory apparatus, educational apparatus and simulators; Analysis apparatus for conducting and evaluating histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, PCR (polymerase chain reaction), NGS (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry and isolation of biomolecules including DNA, RNA and proteins; Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids, Analysis apparatus for research laboratories for measuring, testing and examining tissue, cells and biomolecules including DNA, RNA and proteins

  • Medical apparatus and instruments; Medical instruments; Medical analytical apparatus for medical purposes; Automatic analyzers for medical diagnosis; Physical analyzers for medical use; Genetic testing apparatus for medical purposes

  • Business management consultancy and advisory services; Operation of businesses [for others]; Running of a holding company, namely business management, Business administration, office functions; Holding company services, Namely of Marketing strategy, professional business and organisational consultancy and management of the business interests of others and legally independent companies; Business management and organization consultancy; Advisory services for business management; Business administration; Office functions; Planning and monitoring of business developments with regard to organisational matters

  • Science and technology services; Medical laboratory services; Medical research laboratory services; Development of pharmaceutical preparations and medicines; Clinical research; Research relating to biotechnology; Scientific consultancy services; Biological analysis, Biochemical analysis, Chemical analysis, Scientific analysis; Scientific research in the field of genetics and genetic engineering

  • Medical services; Diagnostic services; In-vitro diagnostic services; Medical services, in relation to the following fields: pathology, genetic science, Human genetics, molecular pathologies, Molecular biology, Microbiology, Biotechnology and laboratory medicine; Medical services by means of histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, PCR (polymerase chain reaction), NGS (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry and isolation of biomolecules including DNA, RNA and proteins; Medical counseling; Pharmaceutical services; Pharmaceutical advice; Medical and health services relating to DNA, genetics and genetic testing; Pathology services; Genetic testing for medical purposes

History

What has happened so far

Steps recorded by the EUIPO, newest first.

  1. Bulletin 2024/053 Section C.3.6
  2. Bulletin 2023/173 Section B.1
  3. Bulletin 2023/102 Section A.1
FAQ

About Zytomics

Who owns the trademark "Zytomics"?

The EUIPO trademark "Zytomics" (application 018870803) is owned by ZytoVision GmbH.

What is the status of "Zytomics"?

Its status at the EUIPO is: registered.

When was "Zytomics" registered?

It was registered on September 12, 2023 and is due to expire on May 5, 2033.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Zytomics and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d4535-f37b-7377-97f4-6364c36e800f
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d4535-f37b-7377-97f4-6364c36e800f",
  "object": "trademark",
  "mark_text": "Zytomics",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "EM",
  "application_number": "018870803",
  "filing_date": "2023-05-05",
  "nice_classes": [
    1,
    5,
    9,
    10,
    35,
    42,
    44
  ],
  "owners": [
    {
      "name": "ZytoVision GmbH",
      "entity_id": "ent_019ebb42-4bb0-720d-b356-e1fc66cf253e"
    }
  ]
}